Man Group PLC Vanda Pharmaceuticals Inc. Transaction History

Man Group PLC

  • $38.1 Billion
  • Q1 2024

A detailed history of Man Group PLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Man Group PLC holds 47,730 shares of VNDA stock, worth $243,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,730
Holding current value
$243,900
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$3.47 - $4.61 $165,623 - $220,035
47,730 New
47,730 $196,000
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $3,441 - $5,282
-804 Reduced 0.29%
272,317 $1.18 Million
Q2 2023

Aug 14, 2023
BUY
$5.9 - $6.95 $1.19 Million - $1.4 Million
201,789 Added 282.89%
273,121 $1.8 Million
Q1 2023

May 15, 2023
SELL
$6.18 - $7.99 $522,537 - $675,578
-84,553 Reduced 54.24%
71,332 $484,000
Q4 2022

Feb 14, 2023
BUY
$6.87 - $10.96 $210,819 - $336,329
30,687 Added 24.51%
155,885 $1.15 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $247,696 - $308,570
26,239 Added 26.52%
125,198 $1.24 Million
Q2 2022

Aug 15, 2022
BUY
$9.31 - $11.84 $406,297 - $516,709
43,641 Added 78.89%
98,959 $1.08 Million
Q1 2022

May 16, 2022
BUY
$10.84 - $16.55 $599,647 - $915,512
55,318 New
55,318 $625,000
Q2 2021

Aug 16, 2021
SELL
$15.71 - $21.51 $453,704 - $621,208
-28,880 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$13.42 - $20.28 $3.95 Million - $5.97 Million
-294,392 Reduced 91.07%
28,880 $434,000
Q4 2020

Feb 16, 2021
SELL
$9.77 - $13.81 $209,078 - $295,534
-21,400 Reduced 6.21%
323,272 $4.25 Million
Q3 2020

Nov 16, 2020
SELL
$9.32 - $12.02 $205,040 - $264,440
-22,000 Reduced 6.0%
344,672 $3.33 Million
Q2 2020

Aug 14, 2020
SELL
$9.66 - $12.02 $433,540 - $539,457
-44,880 Reduced 10.91%
366,672 $4.2 Million
Q1 2020

May 15, 2020
BUY
$7.5 - $16.8 $899,287 - $2.01 Million
119,905 Added 41.11%
411,552 $4.26 Million
Q4 2019

Feb 18, 2020
BUY
$12.38 - $17.47 $2 Million - $2.83 Million
161,927 Added 124.83%
291,647 $4.79 Million
Q3 2019

Nov 14, 2019
BUY
$12.27 - $15.79 $1.59 Million - $2.05 Million
129,720 New
129,720 $1.72 Million
Q2 2019

Aug 14, 2019
SELL
$13.37 - $18.85 $196,819 - $277,490
-14,721 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$17.59 - $31.05 $1.22 Million - $2.16 Million
-69,499 Reduced 82.52%
14,721 $271,000
Q4 2018

Feb 14, 2019
SELL
$18.97 - $31.47 $2.12 Million - $3.52 Million
-111,815 Reduced 57.04%
84,220 $2.2 Million
Q3 2018

Nov 14, 2018
SELL
$18.25 - $23.0 $1.98 Million - $2.5 Million
-108,537 Reduced 35.64%
196,035 $4.5 Million
Q2 2018

Aug 14, 2018
SELL
$13.95 - $19.15 $2.96 Million - $4.06 Million
-212,028 Reduced 41.04%
304,572 $5.8 Million
Q1 2018

May 15, 2018
BUY
$14.05 - $20.2 $7.26 Million - $10.4 Million
516,600 New
516,600 $8.71 Million

Others Institutions Holding VNDA

# of Institutions
147
Shares Held
49.6M
Call Options Held
49.1K
Put Options Held
107K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $289M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email